Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood–retinal barrier

[1]  R. Frank.  Chapter 66 – Etiologic Mechanisms in Diabetic Retinopathy , 2005 .

[2]  R. D. Lynch,et al.  The tight junction: a multifunctional complex. , 2004, American journal of physiology. Cell physiology.

[3]  P. Campochiaro,et al.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema , 2004, Documenta Ophthalmologica.

[4]  P. Artursson,et al.  A new principle for tight junction modulation based on occludin peptides. , 2003, Molecular pharmacology.

[5]  Yuichi Kaji,et al.  The role of advanced glycation end products in retinal microvascular leukostasis. , 2003, Investigative ophthalmology & visual science.

[6]  R. Caldwell,et al.  Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. , 2003, The American journal of pathology.

[7]  Y. Okada,et al.  Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. , 2003, Investigative ophthalmology & visual science.

[8]  R. Caldwell,et al.  VEGF‐induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  S. Tsukita,et al.  Dynamic behavior of paired claudin strands within apposing plasma membranes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. Graier,et al.  Vascular targets of redox signalling in diabetes mellitus , 2002, Diabetologia.

[11]  W. Schaper,et al.  Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. , 2002, Microvascular research.

[12]  E. Dejana,et al.  Interendothelial Junctions and their Role in the Control of Angiogenesis, Vascular Permeability and Leukocyte Transmigration , 2001, Thrombosis and Haemostasis.

[13]  P. Tsao,et al.  Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. , 2001, Circulation research.

[14]  A. Adamis,et al.  Sensitive blood-retinal barrier breakdown quantitation using Evans blue. , 2001, Investigative ophthalmology & visual science.

[15]  R. Borchardt,et al.  VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. , 2001, American journal of physiology. Heart and circulatory physiology.

[16]  F. Cipollone,et al.  Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[17]  Kangsheng Wang,et al.  Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction. , 2000, Analytical biochemistry.

[18]  M. Grant,et al.  Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. , 2000, Free radical biology & medicine.

[19]  B. Nielsen,et al.  Functional overlap between two classes of matrix‐degrading proteases in wound healing , 1999, The EMBO journal.

[20]  T. Gardner,et al.  Vascular Endothelial Growth Factor Induces Rapid Phosphorylation of Tight Junction Proteins Occludin and Zonula Occluden 1 , 1999, The Journal of Biological Chemistry.

[21]  A. Das,et al.  Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. , 1999, Archives of ophthalmology.

[22]  E. Dejuan,et al.  Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. , 1999, Investigative ophthalmology & visual science.

[23]  T. Gardner,et al.  Molecular mechanisms of vascular permeability in diabetic retinopathy. , 1999, Seminars in ophthalmology.

[24]  V. J. Venema,et al.  VEGF-induced permeability increase is mediated by caveolae. , 1999, Investigative ophthalmology & visual science.

[25]  J. Tarbell,et al.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.

[26]  R. Tarnuzzer,et al.  Matrix Metalloproteinase Expression in Human Retinal Microvascular Cells , 1998, Diabetes.

[27]  M. Cooper,et al.  Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[28]  Kazushi Fujimoto,et al.  Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.

[29]  W. Stetler-Stevenson,et al.  72-kDa Gelatinase (Gelatinase A): Structure, Activation, Regulation, and Substrate Specificity , 1998 .

[30]  D. Paul,et al.  COOH Terminus of Occludin Is Required for Tight Junction Barrier Function in Early Xenopus Embryos , 1997, The Journal of cell biology.

[31]  B. Gumbiner,et al.  A Synthetic Peptide Corresponding to the Extracellular Domain of Occludin Perturbs the Tight Junction Permeability Barrier , 1997, The Journal of cell biology.

[32]  M. Balda,et al.  Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.

[33]  K. Nakagawa,et al.  The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. , 1996, Laboratory investigation; a journal of technical methods and pathology.